MRI EVALUATION OF HETEROGENEOUS TISSUE
    6.
    发明申请
    MRI EVALUATION OF HETEROGENEOUS TISSUE 审中-公开
    异位组织的MRI评估

    公开(公告)号:US20160199517A1

    公开(公告)日:2016-07-14

    申请号:US14992847

    申请日:2016-01-11

    IPC分类号: A61K49/10

    CPC分类号: A61K49/08

    摘要: The methods of the invention exploit the capabilities of manganese-enhanced MRI (MEMRI), which provides viability-specific biological contrast agent through the intracellular accumulation of Mn2+. A typical contrast agent utilizes non-chelated Mn2+ in combination with Ca2+, e.g. as calcium gluconate. Active intracellular accumulation of Mn2+ generates high signal from the viable cells in normal tissue, or normal regions of heterogeneous tissue; no signal from the non-viable cells; and intermediate signal from viable but injured cells. The intermediate signal defines a “gray zone” of potentially salvageable cells.

    摘要翻译: 本发明的方法利用锰增强MRI(MEMRI)的能力,其通过Mn2 +的细胞内积累提供生存特异性生物造影剂。 典型的造影剂使用非螯合Mn2 +与Ca2 +组合,例如, 如葡萄糖酸钙。 Mn2 +的活跃细胞内积累从正常组织中的活细胞或异质组织的正常区域产生高信号; 没有来自非活细胞的信号; 和来自活的但受损的细胞的中间信号。 中间信号定义了潜在可抢救细胞的“灰色区域”。